Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by heterogeneous clinical manifestations and multi-organ involvement. Current understanding of SLE pathogenesis remains limited, particularly due to the cellular and molecular diversity of immune cells across tissues. Therefore, a comprehensive review synthesizing recent advances in applying single-cell technologies to SLE research is urgently needed to bridge this knowledge gap.
Technology
Single-cell RNA sequencing (scRNA-seq) provides high-resolution transcriptomic profiling at the single-cell level. This technology facilitates the identification of rare cell subsets, the characterization of cellular states, and the elucidation of disease-specific gene expression patterns. This technology has been applied to various SLE sample types, including peripheral blood, kidney, skin, and bone marrow.
Results
ScRNA-seq has revealed distinct immune cell subpopulations and their functional alterations in SLE, including aberrant B- and T-cell subsets, dysregulated interferon-stimulated genes, and pathogenic low-density granulocytes. Crucially, by deconvoluting this cellular heterogeneity, these high-resolution insights bridge the gap between fundamental pathogenesis and clinical application, uncovering cell-specific pathways that can be harnessed as actionable therapeutic targets and prognostic biomarkers. Integration with spatial transcriptomics and machine learning further enhances research capabilities. These tools allow for mapping disease-specific immune niches and predicting clinical outcomes. Ultimately, these findings underscore the transformative potential of scRNA-seq in decoding SLE pathogenesis and guiding future targeted therapies.
GiannouliSVoulgarelisMZiakasPD, et al.Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis2006; 65(2): 144–148. https://doi.org/10.1136/ard.2005.041673
5.
SantacruzJCMantillaMJRuedaI, et al.A practical perspective of the hematologic manifestations of systemic lupus erythematosus. Cureus2022; 14(3): e22938. https://doi.org/10.7759/cureus.22938
6.
SunSUrbanusRTTen CateH, et al. Platelet activation mechanisms and consequences of immune thrombocytopenia. Cells2021; 10(12): 3386.
AraziARaoDABerthierCC, et al.The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol2019; 20(7): 902–914. https://doi.org/10.1038/s41590-019-0398-x
9.
DerESuryawanshiHBuyonJ, et al.Single-cell RNA sequencing for the study of lupus nephritis. Lupus Sci Med2019; 6(1): e000329. https://doi.org/10.1136/lupus-2019-000329
10.
PanousisNIBertsiasGKOngenH, et al.Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann Rheum Dis2019; 78(8): 1079–1089. https://doi.org/10.1136/annrheumdis-2018-214379
KamalAKhamashtaM. The efficacy of novel B cell biologics as the future of SLE treatment: a review. Autoimmun Rev2014; 13(11): 1094–1101. https://doi.org/10.1016/j.autrev.2014.08.020
13.
DörnerTLipskyPE. Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. Nat Rev Rheumatol2016; 12(11): 645–657. https://doi.org/10.1038/nrrheum.2016.158
14.
MoysidouEChristodoulouMLiouliosG, et al.Lymphocytes change their phenotype and function in systemic lupus erythematosus and lupus nephritis. Int J Mol Sci2024; 25(20): 10905. https://doi.org/10.3390/ijms252010905
15.
GatevaVSandlingJKHomG, et al.A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet2009; 41(11): 1228–1233. https://doi.org/10.1038/ng.468
16.
MorrisDLFernandoMMTaylorKE, et al.MHC associations with clinical and autoantibody manifestations in European SLE. Gene Immun2014; 15(4): 210–217. https://doi.org/10.1038/gene.2014.6
17.
HomGGrahamRRModrekB, et al.Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med2008; 358(9): 900–909. https://doi.org/10.1056/NEJMoa0707865
18.
ShlomchikMJCraftJEMamulaMJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol2001; 1(2): 147–153. https://doi.org/10.1038/35100573
NickersonKMCullenJLKashgarianM, et al.Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1. J Immunol2013; 190(8): 3889–3894. https://doi.org/10.4049/jimmunol.1203525
21.
YuBQiYLiR, et al.B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell2021; 184(7): 1790–1803.e17. https://doi.org/10.1016/j.cell.2021.02.015
22.
Nehar-BelaidDHongSMarchesR, et al.Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol2020; 21(9): 1094–1106. https://doi.org/10.1038/s41590-020-0743-0
23.
WuCJiangSChenZ, et al. Single-cell transcriptomics reveal potent extrafollicular B cell response linked with granzyme K(+) CD8 T cell activation in lupus kidney. Ann Rheum Dis. Published online October; 17: 2024.
24.
KuboTUchidaYWatanabeY, et al.Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J Exp Med2009; 206(9): 1971–1982. https://doi.org/10.1084/jem.20082392
25.
JellusovaJWellmannUAmannK, et al.CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J Immunol2010; 184(7): 3618–3627. https://doi.org/10.4049/jimmunol.0902711
26.
WilkinsonRLyonsABRobertsD, et al.Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood2002; 100(1): 184–193. https://doi.org/10.1182/blood-2002-01-0027
27.
TaubmannJMüllerFYalcin MutluM, et al.CD19 chimeric antigen receptor T cell treatment: unraveling the role of B cells in systemic lupus erythematosus. Arthritis Rheumatol2024; 76(4): 497–504. https://doi.org/10.1002/art.42784
28.
BhamidipatiKSilbersteinJLChaichianY, et al.CD52 is elevated on B cells of SLE patients and regulates B cell function. Front Immunol2020; 11: 626820. https://doi.org/10.3389/fimmu.2020.626820
29.
LvJChenLZhaoL. Renoprotective anti-CD45RB antibody induces B cell production in systemic lupus erythematosus based on single-cell RNA-seq analysis. J Autoimmun2023; 134: 102949. https://doi.org/10.1016/j.jaut.2022.102949
30.
LiHBoulougouraAEndoY, et al.Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun2022; 132: 102870. https://doi.org/10.1016/j.jaut.2022.102870
31.
BalogJZvaraÁBukovinszkiV, et al.Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed light on disease-specific composition of the peripheral immune system. Front Immunol2024; 15: 1376933. https://doi.org/10.3389/fimmu.2024.1376933
32.
PerezRKGordonMGSubramaniamM, et al.Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science2022; 376(6589): eabf1970. https://doi.org/10.1126/science.abf1970
33.
XiongHCuiMKongN, et al.Cytotoxic CD161(-)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus. EBioMedicine2023; 90: 104507. https://doi.org/10.1016/j.ebiom.2023.104507
34.
MoultonVRSuarez-FueyoAMeidanE, et al.Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med2017; 23(7): 615–635. https://doi.org/10.1016/j.molmed.2017.05.006
35.
SuáREZ-FueyoABradleySJKlatzmannD, et al.T cells and autoimmune kidney disease. Nat Rev Nephrol2017; 13(6): 329–343. https://doi.org/10.1038/nrneph.2017.34
36.
ChenPMTsokosGC. The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update. Curr Opin Rheumatol2021; 33(6): 586–591. https://doi.org/10.1097/bor.0000000000000815
37.
GuoCLiuQZongD, et al.Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus. Cell Rep2022; 41(6): 111606. https://doi.org/10.1016/j.celrep.2022.111606
38.
LeeJMChenMHChouKY, et al.Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response. Lupus Sci Med2022; 9(1): e000693. https://doi.org/10.1136/lupus-2022-000693
39.
LiuCYuZSongY, et al.Single-cell RNA sequencing of peripheral blood mononuclear cells from pregnant women with systemic lupus erythematosus. Int Rev Immunol2024; 43(6): 381–393. https://doi.org/10.1080/08830185.2024.2376649
40.
SzekaneczZMcinnesIBSchettG, et al.Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol2021; 17(10): 585–595. https://doi.org/10.1038/s41584-021-00652-9
41.
WangYFuZLiX, et al.Cytoplasmic DNA sensing by KU complex in aged CD4(+) T cell potentiates T cell activation and aging-related autoimmune inflammation. Immunity2021; 54(4): 632–647.e9. https://doi.org/10.1016/j.immuni.2021.02.003
ZhongJDingRJiangH, et al.Single-cell RNA sequencing reveals the molecular features of peripheral blood immune cells in children, adults and centenarians. Front Immunol2022; 13: 1081889. https://doi.org/10.3389/fimmu.2022.1081889
44.
GotoMTakahashiHYoshidaR, et al.Age-associated CD4(+) T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity. Sci Immunol2024; 9(93): eadk1643. https://doi.org/10.1126/sciimmunol.adk1643
45.
HuSTaoDHeP. Immunophenotyping of lymphocyte T and B in the peripheral blood of systemic lupus erythematosus. J Tongji Med Univ2001; 21(2): 108–109. https://doi.org/10.1007/BF02888069
46.
GaoFTanYLuoH. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL. Braz J Med Biol Res2020; 53(5): e9292. https://doi.org/10.1590/1414-431X20209292
47.
StockfeltMLarssonGEngströMH, et al.Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies. Lupus Sci Med2021; 8(1): e000463. https://doi.org/10.1136/lupus-2020-000463
MistryPNakaboSO’NeilL, et al.Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A2019; 116(50): 25222–25228. https://doi.org/10.1073/pnas.1908576116
50.
ZhangYZongLZhengY, et al.A single-cell atlas of the peripheral immune response in patients with influenza A virus infection. iScience2023; 26(12): 108507. https://doi.org/10.1016/j.isci.2023.108507
51.
BorrelliCGurtnerAArnoldIC, et al.Stress-free single-cell transcriptomic profiling and functional genomics of murine eosinophils. Nat Protoc2024; 19(6): 1679–1709. https://doi.org/10.1038/s41596-024-00967-3
RönnblomLLeonardD. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med2019; 6(1): e000270. https://doi.org/10.1136/lupus-2018-000270
54.
BennettLPaluckaAKArceE, et al.Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med2003; 197(6): 711–723. https://doi.org/10.1084/jem.20021553
MunroeMELuRZhaoYD, et al.Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheum Dis2016; 75(11): 2014–2021. https://doi.org/10.1136/annrheumdis-2015-208140
58.
DengYZhengYLiD, et al.Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. EBioMedicine2021; 70: 103477. https://doi.org/10.1016/j.ebiom.2021.103477
59.
CaielliSCardenasJDe JesusAA, et al.Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell2021; 184(17): 4464–4479.e19. https://doi.org/10.1016/j.cell.2021.07.021
60.
WangJLinQLangstonH, et al.Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity1995; 3(4): 475–484. https://doi.org/10.1016/1074-7613(95)90176-0
61.
PalanichamyABauerJWYalavarthiS, et al.Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol2014; 192(3): 906–918. https://doi.org/10.4049/jimmunol.1302112
Illescas-MontesRCorona-CastroCCMelguizo-RodríguezL, et al.Infectious processes and systemic lupus erythematosus. Immunology2019; 158(3): 153–160. https://doi.org/10.1111/imm.13103
64.
OelenRDe VriesDHBruggeH, et al.Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals widespread, context-specific gene expression regulation upon pathogenic exposure. Nat Commun2022; 13(1): 3267. https://doi.org/10.1038/s41467-022-30893-5
65.
UedaYYangKFosterSJ, et al.Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med2004; 199(1): 47–58. https://doi.org/10.1084/jem.20031104
66.
MaedaKMalykhinATeague-WeberBN, et al.Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood2009; 113(19): 4534–4540. https://doi.org/10.1182/blood-2008-12-192559
67.
PattersonSLVan PhanHYeCJ, et al.Physical inactivity exacerbates pathologic inflammatory signalling at the single cell level in patients with systemic lupus. EBioMedicine2024; 110: 105432. https://doi.org/10.1016/j.ebiom.2024.105432
68.
CuiYZhangHWangZ, et al.Exploring the shared molecular mechanisms between systemic lupus erythematosus and primary Sjögren’s syndrome based on integrated bioinformatics and single-cell RNA-seq analysis. Front Immunol2023; 14: 1212330. https://doi.org/10.3389/fimmu.2023.1212330
69.
Ghodke-PuranikYJinZZimmermanKD, et al.Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes. Arthritis Res Ther2021; 23(1): 290. https://doi.org/10.1186/s13075-021-02660-2
70.
LiYMaCLiaoS, et al.Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus. Front Immunol2022; 13: 969509. https://doi.org/10.3389/fimmu.2022.969509
CostenbaderKHDesaiAAlarcóNGS, et al.Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum2011; 63(6): 1681–1688. https://doi.org/10.1002/art.30293
TektonidouMGDasguptaAWardMM. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol2016; 68(6): 1432–1441. https://doi.org/10.1002/art.39594
75.
LiarskiVMKaverinaNChangA, et al.Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med2014; 6(230): 230ra46. https://doi.org/10.1126/scitranslmed.3008146
76.
HutloffABüchnerKReiterK, et al.Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum2004; 50(10): 3211–3220. https://doi.org/10.1002/art.20519
77.
KassianosAJWangXSampangiS, et al.Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease. Am J Physiol Renal Physiol2013; 305(10): F1391–F1401. https://doi.org/10.1152/ajprenal.00318.2013
78.
RaoDAAraziAWofsyD, et al.Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis. Nat Rev Nephrol2020; 16(4): 238–250. https://doi.org/10.1038/s41581-019-0232-6
79.
ParkJShresthaRQiuC, et al.Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science2018; 360(6390): 758–763. https://doi.org/10.1126/science.aar2131
80.
PamfilCMakowskaZDe GroofA, et al.Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis. Ann Rheum Dis2018; 77(12): 1782–1789. https://doi.org/10.1136/annrheumdis-2018-213485
81.
WangSWangJKumarV, et al.IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun2018; 9(1): 1758. https://doi.org/10.1038/s41467-018-03750-7
82.
WuCFuQGuoQ, et al.Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated. Ann Rheum Dis2019; 78(8): 1090–1100. https://doi.org/10.1136/annrheumdis-2019-215039
83.
TangYZhangYLiX, et al.Immune landscape and the key role of APOE+ monocytes of lupus nephritis under the single-cell and spatial transcriptional vista. Clin Transl Med2023; 13(4): e1237. https://doi.org/10.1002/ctm2.1237
84.
ChenWJinBChengC, et al.Single-cell profiling reveals kidney CD163(+) dendritic cell participation in human lupus nephritis. Ann Rheum Dis2024; 83(5): 608–623. https://doi.org/10.1136/ard-2023-224788
85.
SahuRBethunaickanRSinghS, et al.Structure and function of renal macrophages and dendritic cells from lupus-prone mice. Arthritis Rheumatol2014; 66(6): 1596–1607. https://doi.org/10.1002/art.38410
86.
YapDYLaiKN. Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities. Int J Mol Sci2015; 16(4): 7917–7931. https://doi.org/10.3390/ijms16047917
87.
ZhouCBaiXYangY, et al.Single-cell sequencing informs that mesenchymal stem cell alleviates renal injury through regulating kidney regional immunity in lupus nephritis. Stem Cells Dev2023; 32(15–16): 465–483. https://doi.org/10.1089/scd.2023.0047
88.
MouLZhangFLiuX, et al.Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics. Front Immunol2024; 15: 1309447. https://doi.org/10.3389/fimmu.2024.1309447
89.
FavaABuyonJMohanC, et al.Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis. JCI Insight2020; 5(12): e138345. https://doi.org/10.1172/jci.insight.138345
90.
DerESuryawanshiHMorozovP, et al.Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol2019; 20(7): 915–927. https://doi.org/10.1038/s41590-019-0386-1
91.
DanaherPHasleNNguyenED, et al.Childhood-onset lupus nephritis is characterized by complex interactions between kidney stroma and infiltrating immune cells. Sci Transl Med2024; 16(775): eadl1666. https://doi.org/10.1126/scitranslmed.adl1666
92.
StullCSprowGWerthVP. Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist. J Rheumatol2023; 50(1): 27–35. https://doi.org/10.3899/jrheum.220089
93.
HannonCWMccourtCLimaHC, et al.Interventions for cutaneous disease in systemic lupus erythematosus. Cochrane Database Syst Rev2021; 3(3): Cd007478. https://doi.org/10.1002/14651858.cd007478.pub2
94.
ZhengMHuZMeiX, et al.Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus. Nat Commun2022; 13(1): 7489. https://doi.org/10.1038/s41467-022-35209-1
95.
Abernathy-CloseLLazarSStannardJ, et al.B cell signatures distinguish cutaneous lupus erythematosus subtypes and the presence of systemic disease activity. Front Immunol2021; 12: 775353. https://doi.org/10.3389/fimmu.2021.775353
96.
MagroCMSegalJPCrowsonAN, et al.The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. J Cutan Pathol2010; 37(6): 659–671. https://doi.org/10.1111/j.1600-0560.2009.01443.x
97.
DunlapGSBilliACXingX, et al.Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney. JCI Insight2022; 7(8): e156341. https://doi.org/10.1172/jci.insight.156341
98.
ZhengYWangSZhouX, et al.Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients. Sci Bull (Beijing)2025; 70(1): 42–46. https://doi.org/10.1016/j.scib.2024.05.038
99.
GaoMLiuSChathamWW, et al.IL-4-Induced quiescence of resting naive B cells is disrupted in systemic lupus erythematosus. J Immunol2022; 209(8): 1513–1522. https://doi.org/10.4049/jimmunol.2200409
100.
DongCGuoYChenZ, et al.Single-cell profiling of bone marrow B cells and early B cell developmental disorders associated with systemic lupus erythematosus. Arthritis Rheumatol2024; 76(4): 599–613. https://doi.org/10.1002/art.42750
101.
PetersonJNBoackleSATaitanoSH, et al.Elevated detection of dual antibody B cells identifies lupus patients with B cell-reactive VH4-34 autoantibodies. Front Immunol2022; 13: 795209. https://doi.org/10.3389/fimmu.2022.795209
102.
DaamenARAlajoleenRMGrammerAC, et al.Single-cell RNA sequencing analysis reveals the heterogeneity of IL-10 producing regulatory B cells in lupus-prone mice. Front Immunol2023; 14: 1282770. https://doi.org/10.3389/fimmu.2023.1282770
103.
FiliaAMitroulisILoukogiannakiC, et al.Single-cell transcriptomic analysis of hematopoietic progenitor cells from patients with systemic lupus erythematosus reveals interferon-inducible reprogramming in early progenitors. Front Immunol2024; 15: 1383358. https://doi.org/10.3389/fimmu.2024.1383358
104.
MartinMGuffroyAArgemiX, et al.[Systemic lupus erythematosus and lymphopenia: clinical and pathophysiological features]. Rev Med Interne2017; 38(9): 603–613. https://doi.org/10.1016/j.revmed.2017.01.005
PapadakiHABoumpasDTGibsonFM, et al.Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol2001; 115(1): 167–174. https://doi.org/10.1046/j.1365-2141.2001.03076.x
107.
KandarakovOBelyavskyASemenovaE. Bone marrow niches of hematopoietic stem and progenitor cells. Int J Mol Sci2022; 23(8): 4462. https://doi.org/10.3390/ijms23084462
108.
WangJCDoedensMDickJE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood1997; 89(11): 3919–3924.
SchulzCGomez PerdigueroEChorroL, et al.A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science2012; 336(6077): 86–90. https://doi.org/10.1126/science.1219179
111.
HashimotoDChowANoizatC, et al.Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity2013; 38(4): 792–804. https://doi.org/10.1016/j.immuni.2013.04.004
112.
BeaudinAEBoyerSWPerez-CunninghamJ, et al.A transient developmental hematopoietic stem cell gives rise to innate-like B and T cells. Cell Stem Cell2016; 19(6): 768–783. https://doi.org/10.1016/j.stem.2016.08.013
113.
LowtherDEGoodsBALuccaLE, et al. PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight2016; 1(5): e85935. https://doi.org/10.1172/jci.insight.85935
114.
MouLLuYWuZ, et al.Integrating genomics and AI to uncover molecular targets for mRNA vaccine development in lupus nephritis. Front Immunol2024; 15: 1381445. https://doi.org/10.3389/fimmu.2024.1381445
115.
DaiYLiuJLaiY, et al.Exploring mitochondrial and ferroptotic mechanisms for systemic lupus erythematosus biomarker identification and therapy. Sci Rep2025; 15(1): 9140. https://doi.org/10.1038/s41598-025-93872-y
116.
WangYHuangZXiaoY, et al.The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis. Front Immunol2022; 13: 1015882. https://doi.org/10.3389/fimmu.2022.1015882
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
